Literature DB >> 16697646

Discovery of new chemical leads for selective EP1 receptor antagonists.

Atsushi Naganawa1, Tetsuji Saito, Yuuki Nagao, Hiromu Egashira, Maki Iwahashi, Tohru Kambe, Masatoshi Koketsu, Hiroshi Yamamoto, Michiyoshi Kobayashi, Takayuki Maruyama, Shuichi Ohuchida, Hisao Nakai, Kigen Kondo, Masaaki Toda.   

Abstract

A series of 4-([2-[alkyl(phenylsulfonyl)amino]phenoxy]methyl)benzoic acids were identified as functional PGE(2) antagonists with selectivity for the EP1 receptor subtype starting from a chemical lead 1, which was found while screening our in-house compound library. Discovery of the optimized analogs 21-23 is presented here and structure-activity relationships (SAR) are also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697646     DOI: 10.1016/j.bmc.2006.04.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potential.

Authors:  Jake Smith; Heather Wescott; Julie Early; Steven Mullen; Junitta Guzman; Joshua Odingo; Jason Lamar; Tanya Parish
Journal:  Medchemcomm       Date:  2019-05-03       Impact factor: 3.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.